New-Onset Diabetes in Covid-19
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
There is a bidirectional relationship between Covid-19 and diabetes. On the one hand, diabetes is associated with an increased risk of severe Covid-19. On the other hand, new-onset diabetes and severe metabolic complications of preexisting diabetes, including diabetic ketoacidosis and hyperosmolarity for which exceptionally high doses of insulin are warranted, have been observed in patients with Covid-19. These manifestations of diabetes pose challenges in clinical management and suggest a complex pathophysiology of Covid-19–related diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
Yang, J.-K., Lin, S.-S., Ji, X.-J., & Guo, L.-M. (2010) · Acta Diabetologica · doi:10.1007/s00592-009-0109-4 · Cited by 1,084
COVID ‐19 infection may cause ketosis and ketoacidosis
Li, J., Wang, X., Chen, J., Zuo, X., Zhang, H., & Deng, A. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14057 · Cited by 455
Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus
Chee, Y. J., Ng, S. J. H., & Yeoh, E. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108166 · Cited by 287
Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19
Ren, H., Yang, Y., Wang, F., Yan, Y., Shi, X., Dong, K., Yu, X., & Zhang, S. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01035-2 · Cited by 200
Cited by
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Human Wound and Its Burden: Updated 2020 Compendium of Estimates
Sen, C. K. (2021) · Advances in Wound Care · doi:10.1089/wound.2021.0026 · Cited by 1,017
Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study
Ayoubkhani, D., Khunti, K., Nafilyan, V., Maddox, T., Humberstone, B., Diamond, I., & Banerjee, A. (2021) · BMJ · doi:10.1136/bmj.n693 · Cited by 832
Self-citationThe Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
Pathological sequelae of long-haul COVID
Mehandru, S., & Merad, M. (2022) · Nature Immunology · doi:10.1038/s41590-021-01104-y · Cited by 657
Risks and burdens of incident diabetes in long COVID: a cohort study
Xie, Y., & Al-Aly, Z. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00044-4 · Cited by 564
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
Müller, J. A., Groß, R., Conzelmann, C., Krüger, J., Merle, U., Steinhart, J., Weil, T., Koepke, L., Bozzo, C. P., Read, C., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00347-1 · Cited by 552
The SARS-CoV-2 as an instrumental trigger of autoimmunity
Dotan, A., Muller, S., Kanduc, D., David, P., Halpert, G., & Shoenfeld, Y. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102792 · Cited by 494
Long-term complications of COVID-19
Desai, A. D., Lavelle, M., Boursiquot, B. C., & Wan, E. Y. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00375.2021 · Cited by 415
Global pandemics interconnected — obesity, impaired metabolic health and COVID-19
Stefan, N., Birkenfeld, A. L., & Schulze, M. B. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00462-1 · Cited by 452
Human Wound and Its Burden: Updated 2022 Compendium of Estimates
Sen, C. K. (2023) · Advances in Wound Care · doi:10.1089/wound.2023.0150 · Cited by 360
Systemic racism, chronic health inequities, and COVID‐19: A syndemic in the making?
Gravlee, C. C. (2020) · American Journal of Human Biology · doi:10.1002/ajhb.23482 · Cited by 374
SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment
Wu, C.-T., Lidsky, P. V., Xiao, Y., Lee, I. T., Cheng, R., Nakayama, T., Jiang, S., Demeter, J., Bevacqua, R. J., Chang, C. A., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.05.013 · Cited by 364
Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss
Kirwan, R., McCullough, D., Butler, T., Perez de Heredia, F., Davies, I. G., & Stewart, C. (2020) · GeroScience · doi:10.1007/s11357-020-00272-3 · Cited by 324
COVID-19, Hyperglycemia, and New-Onset Diabetes
Khunti, K., Del Prato, S., Mathieu, C., Kahn, S. E., Gabbay, R. A., & Buse, J. B. (2021) · Diabetes Care · doi:10.2337/dc21-1318 · Cited by 320
Self-citationPeluso, M. J., Lu, S., Tang, A. F., Durstenfeld, M. S., Ho, H.-E., Goldberg, S. A., Forman, C. A., Munter, S. E., Hoh, R., Tai, V., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab490 · Cited by 320
Long-term consequences of COVID-19: research needs
Yelin, D., Wirtheim, E., Vetter, P., Kalil, A. C., Bruchfeld, J., Runold, M., Guaraldi, G., Mussini, C., Gudiol, C., Pujol, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30701-5 · Cited by 311
COVID-19: A review of therapeutic strategies and vaccine candidates
Izda, V., Jeffries, M. A., & Sawalha, A. H. (2021) · Clinical Immunology · doi:10.1016/j.clim.2020.108634 · Cited by 274
Proportion of newly diagnosed diabetes in COVID ‐19 patients: A systematic review and meta‐analysis
Sathish, T., Kapoor, N., Cao, Y., Tapp, R. J., & Zimmet, P. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14269 · Cited by 251
Self-citationCOVID-19 and metabolic disease: mechanisms and clinical management
Steenblock, C., Schwarz, P. E. H., Ludwig, B., Linkermann, A., Zimmet, P., Kulebyakin, K., Tkachuk, V. A., Markov, A. G., Lehnert, H., de Angelis, M. H., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00244-8 · Cited by 246
Self-citationPathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
Sherif, Z. A., Gomez, C. R., Connors, T. J., Henrich, T. J., Reeves, W. B., & RECOVER Mechanistic Pathway Task Force (2023) · eLife · doi:10.7554/elife.86002 · Cited by 237
Pillon, N. J., Loos, R. J. F., Marshall, S. M., & Zierath, J. R. (2021) · Cell · doi:10.1016/j.cell.2021.02.012 · Cited by 234
Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19
Ramakrishnan, R. K., Kashour, T., Hamid, Q., Halwani, R., & Tleyjeh, I. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.686029 · Cited by 235
Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?
Rabbone, I., Schiaffini, R., Cherubini, V., Maffeis, C., Scaramuzza, A., Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes, Bertelli, E., Ferlito, L., Bobbio, A., Schieven, E., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1321 · Cited by 218
Fignani, D., Licata, G., Brusco, N., Nigi, L., Grieco, G. E., Marselli, L., Overbergh, L., Gysemans, C., Colli, M. L., Marchetti, P., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.596898 · Cited by 205
COVID-19 y diabetes mellitus: una relación bidireccional
Lima-Martínez, M. M., Carrera Boada, C., Madera-Silva, M. D., Marín, W., & Contreras, M. (2021) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.10.001 · Cited by 172
Liu, J., Liu, M., Chai, Z., Li, C., Wang, Y., Shen, M., Zhuang, G., & Zhang, L. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2023.100700 · Cited by 187
Self-citationViral infiltration of pancreatic islets in patients with COVID-19
Steenblock, C., Richter, S., Berger, I., Barovic, M., Schmid, J., Schubert, U., Jarzebska, N., von Mässenhausen, A., Linkermann, A., Schürmann, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23886-3 · Cited by 181
Self-citationSingh, A. K., & Singh, R. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108382 · Cited by 180
New onset diabetes, type 1 diabetes and COVID-19
Boddu, S. K., Aurangabadkar, G., & Kuchay, M. S. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.11.012 · Cited by 185
“hyperglycemia, confirmed COVID-19, a negative history of diabetes, and a history of a normal glycated hemoglobin level [73].”
Xie, Y., Bowe, B., Maddukuri, G., & Al-Aly, Z. (2020) · BMJ · doi:10.1136/bmj.m4677 · Cited by 181
Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report
Hollstein, T., Schulte, D. M., Schulz, J., Glück, A., Ziegler, A. G., Bonifacio, E., Wendorff, M., Franke, A., Schreiber, S., Bornstein, S. R., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00281-8 · Cited by 176
Self-citationZhou, Y., Hou, Y., Shen, J., Mehra, R., Kallianpur, A., Culver, D. A., Gack, M. U., Farha, S., Zein, J., Comhair, S., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000970 · Cited by 180
Coppelli, A., Giannarelli, R., Aragona, M., Penno, G., Falcone, M., Tiseo, G., Ghiadoni, L., Barbieri, G., Monzani, F., Virdis, A., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1380 · Cited by 169
Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis
Zhang, T., Mei, Q., Zhang, Z., Walline, J. H., Liu, Y., Zhu, H., & Zhang, S. (2022) · BMC Medicine · doi:10.1186/s12916-022-02656-y · Cited by 158
Animal and translational models of SARS-CoV-2 infection and COVID-19
Johansen, M. D., Irving, A., Montagutelli, X., Tate, M. D., Rudloff, I., Nold, M. F., Hansbro, N. G., Kim, R. Y., Donovan, C., Liu, G., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00340-z · Cited by 173
Rahmati, M., Keshvari, M., Mirnasuri, S., Yon, D. K., Lee, S. W., Il Shin, J., & Smith, L. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27996 · Cited by 158
Why the Patient-Made Term 'Long Covid' is needed
Perego, E., Callard, F. J., Stras, L., Melville-Jóhannesson, B., Pope, R., & Alwan, N. A. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16307.1 · Cited by 190
Cenko, E., Badimón, L., Bugiardini, R., Claeys, M. J., Luca, G. D., de Wit, C., Dérumeaux, G., Dorobanţu, M., Duncker, D. J., Eringa, E. C., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab298 · Cited by 167
Bilich, T., Nelde, A., Heitmann, J. S., Maringer, Y., Roerden, M., Bauer, J., Rieth, J., Wacker, M., Peter, A., Hörber, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf7517 · Cited by 156
Update Advances on C-Reactive Protein in COVID-19 and Other Viral Infections
Luan, Y., Yin, C., & Yao, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.720363 · Cited by 169
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Sun, C., Xie, C., Bu, G., Zhong, L., & Zeng, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01039-2 · Cited by 166
New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic
Salmi, H., Heinonen, S., Hästbacka, J., Lääperi, M., Rautiainen, P., Miettinen, P. J., Vapalahti, O., Hepojoki, J., & Knip, M. (2021) · Archives of Disease in Childhood · doi:10.1136/archdischild-2020-321220 · Cited by 136
COVID-19 in people living with diabetes: An international consensus
Caballero, A. E., Ceriello, A., Misra, A., Aschner, P., McDonnell, M. E., Hassanein, M., Ji, L., Mbanya, J. C., & Fonseca, V. A. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107671 · Cited by 132
Self-citationPáez-Franco, J. C., Torres-Ruiz, J. J., Sosa‐Hernández, V. A., Cervantes‐Díaz, R., Romero‐Ramírez, S., Pérez‐Fragoso, A., Meza-Sánchez, D. E., Germán-Acacio, J. M., Maravillas‐Montero, J. L., Mejía‐Domínguez, N. R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85788-0 · Cited by 138
Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes
Sathish, T., Tapp, R. J., Cooper, M. E., & Zimmet, P. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.10.002 · Cited by 149
Self-citationDiabetes and the COVID-19 pandemic
Khunti, K., Valabhji, J., & Misra, S. (2022) · Diabetologia · doi:10.1007/s00125-022-05833-z · Cited by 141
Self-citationPathogenesis, Clinical Manifestations and Complications of COVID-19
Kordzadeh-Kermani, E., Khalili, H., & Karimzadeh, I. (2020) · Future Microbiology · doi:10.2217/fmb-2020-0110 · Cited by 165
COVID-19 and diabetes: A bidirectional relationship
Lima-Martínez, M. M., Carrera Boada, C., Madera-Silva, M. D., Marín, W., & Contreras, M. (2021) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2021.04.004 · Cited by 38
Impact of COVID-19 on the Endocrine System: A Mini-review
Clarke, S. A., Abbara, A., & Dhillo, W. S. (2021) · Endocrinology · doi:10.1210/endocr/bqab203 · Cited by 122
Lampasona, V., Secchi, M., Scavini, M., Bazzigaluppi, E., Brigatti, C., Marzinotto, I., Davalli, A. M., Caretto, A., Laurenzi, A., Martinenghi, S., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05284-4 · Cited by 119
Potential Interaction Between SARS-CoV-2 and Thyroid: A Review
Chen, W., Tian, Y., Li, Z., Zhu, J., Wei, T., & Lei, J. (2021) · Endocrinology · doi:10.1210/endocr/bqab004 · Cited by 127
Puig‐Domingo, M., Marazuela, M., Yıldız, B. O., & Giustina, A. (2021) · Endocrine · doi:10.1007/s12020-021-02734-w · Cited by 121
Holmes, E. C., Wist, J., Masuda, R., Lodge, S., Nitschke, P., Kimhofer, T., Loo, R. L., Begum, S., Boughton, B. A., Yang, R., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00224 · Cited by 122
SARS‐CoV‐2‐specific virulence factors in COVID‐19
Kumar, A., Prasoon, P., Kumari, C., Pareek, V., Faiq, M. A., Narayan, R. K., Kulandhasamy, M., & Kant, K. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26615 · Cited by 115
Hippich, M., Holthaus, L., Assfalg, R., Zapardiel‐Gonzalo, J., Kapfelsperger, H., Heigermoser, M., Haupt, F., Ewald, D., Welzhofer, T., Marcus, B. A., et al. (2020) · Med · doi:10.1016/j.medj.2020.10.003 · Cited by 127
COVID-19–Induced New-Onset Diabetes: Trends and Technologies
Metwally, A. A., Mehta, P., Johnson, B. S., Nagarjuna, A., & Snyder, M. P. (2021) · Diabetes · doi:10.2337/dbi21-0029 · Cited by 118
Diabetes and COVID-19: The past, the present, and the future
Pranata, R., Henrina, J., Raffaello, W. M., Lawrensia, S., & Huang, I. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154814 · Cited by 123
COVID-19 and diabetes mellitus: how one pandemic worsens the other
Azar, W. S., Njeim, R., Fares, A. H., Azar, N. S., Azar, S. T., Sayed, M. J. E., & Eid, A. A. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09573-6 · Cited by 118
Singh, M. K., Mobeen, A., Chandra, A., Joshi, S. S., & Ramachandran, S. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104219 · Cited by 120
Singh, A. K., & Khunti, K. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-042220-011857 · Cited by 122
Self-citationLee, J. W., Su, Y., Baloni, P., Chen, D., Pavlovitch-Bedzyk, A. J., Yuan, D., Duvvuri, V. R. S. K., Ng, R. H., Choi, J., Xie, J., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-01020-4 · Cited by 120
COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences
Martínez-Salazar, B., Holwerda, M., Stüdle, C., Piragyte, I., Mercader, N., Engelhardt, B., Rieben, R., & Döring, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.824851 · Cited by 114
Long‐term side effects and lingering symptoms post COVID‐19 recovery
Zarei, M., Bose, D., Nouri‐Vaskeh, M., Tajiknia, V., Zand, R., & Ghasemi, M. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2289 · Cited by 110
Association of COVID-19 with diabetes: a systematic review and meta-analysis
Ssentongo, P., Zhang, Y., Witmer, L., Chinchilli, V. M., & Ba, D. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-24185-7 · Cited by 95
Suwanwongse, K., & Shabarek, N. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26339 · Cited by 100
Frara, S., Allora, A., Castellino, L., di Filippo, L., Loli, P., & Giustina, A. (2021) · Pituitary · doi:10.1007/s11102-021-01148-1 · Cited by 112
New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis
Shrestha, D. B., Budhathoki, P., Raut, S., Adhikari, S., Ghimire, P., Thapaliya, S., Rabaan, A. A., & Karki, B. (2021) · World Journal of Virology · doi:10.5501/wjv.v10.i5.275 · Cited by 96
Long COVID-19—it's not over until?
Yelin, D., Margalit, I., Yahav, D., Runold, M., & Bruchfeld, J. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.12.001 · Cited by 101
Diabetes and COVID-19: Population Impact 18 Months Into the Pandemic
Gregg, E. W., Sophiea, M. K., & Weldegiorgis, M. (2021) · Diabetes Care · doi:10.2337/dci21-0001 · Cited by 94
Coronavirus disease 2019 and cardiovascular complications: focused clinical review
Saeed, S., Tadic, M., Larsen, T. H., Grassi, G., & Mancia, G. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002819 · Cited by 93
Hawkins, J., Hires, C., Keenan, L., & Dunne, E. (2022) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2022.102823 · Cited by 102
Rastad, H., Karim, H., Ejtahed, H., Tajbakhsh, R., Noorisepehr, M., Babaei, M., Azimzadeh, M., Soleimani, A., Inanloo, S. H., Hassani, N. S., et al. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00565-9 · Cited by 97
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab
Meoni, G., Ghini, V., Maggi, L., Vignoli, A., Mazzoni, A., Salvati, L., Capone, M., Vanni, A., Tenori, L., Fontanari, P., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009243 · Cited by 99
Deffner, F., Scharr, M., Klingenstein, S., Klingenstein, M., Milazzo, A., Scherer, S., Wagner, A., Hirt, B., Mack, A. F., & Neckel, P. H. (2020) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2020.596439 · Cited by 93
Diabetes and COVID-19; A Bidirectional Interplay
Kazakou, P., Lambadiari, V., Ikonomidis, I., Kountouri, A., Panagopoulos, G. N., Athanasopoulos, S., Korompoki, E., Kalomenidis, I., Dimopoulos, M. A., & Mitrakou, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.780663 · Cited by 96
Environmental Factors and the Risk of Developing Type 1 Diabetes—Old Disease and New Data
Zorena, K., Michalska, M., Kurpas, M., Jaskulak, M., Murawska, A., & Rostami, S. (2022) · Biology · doi:10.3390/biology11040608 · Cited by 100
Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?
Pugliese, G., Vitale, M., Resi, V., & Orsi, E. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01586-6 · Cited by 97
Pasquel, F. J., Messler, J., Booth, R., Kubacka, B., Mumpower, A., Umpierrez, G. E., & Aloi, J. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.1091 · Cited by 88
Molecular mimicry and autoimmunity in the time of COVID-19
Rojas, M., Herrán, M., Ramírez-Santana, C., Leung, P. S. C., Anaya, J.-M., Ridgway, W. M., & Gershwin, M. E. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103070 · Cited by 90
Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role
Samuel, S. M., Varghese, E., & Büsselberg, D. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.03.004 · Cited by 92
Zisis, S. N., Durieux, J. C., Mouchati, C., Perez, J. A., & McComsey, G. A. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac228 · Cited by 85
Alyammahi, S. K., Abdin, S. M., Alhamad, D. W., Elgendy, S. M., Altell, A. T., & Omar, H. A. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104647 · Cited by 92
Lodge, S., Nitschke, P., Kimhofer, T., Coudert, J. D., Begum, S., Bong, S.-H., Richards, T., Edgar, D. W., Raby, E., Spraul, M., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00876 · Cited by 86
The Incidence of Diabetes Among 2,808,106 Veterans With and Without Recent SARS-CoV-2 Infection
Wander, P. L., Lowy, E., Beste, L. A., Tulloch-Palomino, L. G., Korpak, A. M., Peterson, A. C., Kahn, S. E., & Boyko, E. J. (2022) · Diabetes Care · doi:10.2337/dc21-1686 · Cited by 82
Shah, H., Khan, M. S. H., Dhurandhar, N. V., & Hegde, V. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01636-z · Cited by 80
Type 2 diabetes and viral infection; cause and effect of disease
Wensveen, T. T., Gašparini, D., Rahelić, D., & Wensveen, F. M. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108637 · Cited by 94
Gęca, T., Wojtowicz, K., Guzik, P. W., & Góra, T. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116555 · Cited by 88
McGlacken-Byrne, S. M., Drew, S., Turner, K., Peters, C. J., & Amin, R. (2021) · Diabetic Medicine · doi:10.1111/dme.14640 · Cited by 91
The Role of Acidosis in the Pathogenesis of Severe Forms of COVID-19
Nechipurenko, Y. D., Semyonov, D., Lavrinenko, I. A., Lagutkin, D., Generalov, E. A., Zaitceva, A. Y., Matveeva, O. V., & Yegorov, Y. E. (2021) · Biology · doi:10.3390/biology10090852 · Cited by 82
COVID-19 endocrinopathy with hindsight from SARS
Narasimhan, K., Anantharaj, R., Xue, B., Yew, W. S., Velan, S. S., Karnani, N., & Leow, M. K. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00480.2020 · Cited by 82
The Role of Extracellular Vesicles in the Pathogenesis and Treatment of Autoimmune Disorders
Lu, M., DiBernardo, E. F., Parks, E., Fox, H., Zheng, S., & Wayne, E. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.566299 · Cited by 87
Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Jiang, D. H., Roy, D. J., Gu, B., Hassett, L. C., & McCoy, R. G. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.07.002 · Cited by 90
Diabetes, obesity and COVID ‐19: A complex interplay
Vas, P. R. J., Hopkins, D., Feher, M. D., Rubino, F., & Whyte, M. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14134 · Cited by 85
Self-citationCOVID-19 Mechanisms in the Human Body—What We Know So Far
Kumar, A., Narayan, R. K., Prasoon, P., Kumari, C., Kaur, G., Kumar, S., Kulandhasamy, M., Sesham, K., Pareek, V., Faiq, M. A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.693938 · Cited by 82
Whittaker, H., Gulea, C., Koteci, A., Kallis, C., Morgan, A. D., Iwundu, C., Weeks, M., Gupta, R. S., & Quint, J. K. (2021) · BMJ · doi:10.1136/bmj-2021-065834 · Cited by 84
SARS‐CoV‐2, COVID‐19, skin and immunology – What do we know so far?
Novak, N., Peng, W., Nägeli, M., Galvan, C., Kolm‐Djamei, I., Brüggen, M., Cabanillas, B., Schmid‐Grendelmeier, P., & Català, A. (2020) · Allergy · doi:10.1111/all.14498 · Cited by 81
Multisystem effects of COVID-19: a concise review for practitioners
White-Dzuro, G. A., Gibson, L. E., Zazzeron, L., White-Dzuro, C. G., Sullivan, Z. P., Diiorio, D. A., Low, S. A., Chang, M. G., & Bittner, E. A. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1823094 · Cited by 82
Misra, S., Barron, E., Vamos, E. P., Thomas, S., Dhatariya, K., Kar, P. S., Young, B., Khunti, K., & Valabhji, J. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00208-4 · Cited by 75
Self-citation
Metadata
- Authors
- Rubino, F., Amiel, S. A., Zimmet, P., Alberti, G., Bornstein, S., Eckel, R. H., Mingrone, G., Boehm, B., Cooper, M. E., Chai, Z., Del Prato, S., Ji, L., Hopkins, D., Herman, W. H., Khunti, K., Mbanya, J.-C., & Renard, E.
- Affiliations
- King's College London (GB)
- Monash University (AU)
- Imperial College London (GB)
- Technische Universität Dresden (DE)
- University of Colorado Anschutz (US)
- Agostino Gemelli University Polyclinic (IT)
- Nanyang Technological University (SG)
- University of Pisa, Pisa, Italy
- Peking University (CN)
- Kings Health Partners (GB)
- University of Michigan (US)
- University of Leicester (GB)
- Université de Yaoundé I (CM)
- University of Montpellier, Montpellier, France
- Corresponding author
- Rubino, Francesco
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-08-20
- Volume
- 383
- Issue
- 8
- Pages
- 789-790
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC7304415
- OpenAlex
- W3035586023
- Cited by
- 801
- References
- 5
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 58 · 2023: 112 · 2022: 199 · 2021: 258 · 2020: 124
- FWCI
- 22.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- HAL (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Transcampus of Technische Universität Dresden & King’s College London
- King’s College London, London, UK and Monash University, Melbourne Australia
- Institute of Diabetes, Endocrinology, Obesity, King’s Health Partners
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- new-onset diabetes, COVID-19 pandemic, diabetic ketoacidosis, hyperosmolar hyperglycemic state, severe COVID-19, insulin therapy
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Diabetes Mellitus, Glucose, Humans, Pneumonia, Viral, Registries, Global Health, Coronavirus Infections, Diabetes Complications, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.